Recommendations of apex health bodies remain localized: not in conformity with international implementation policy for urological disorders

Abstract

In developing/underdeveloped countries there is still a great burden of adverse drug reaction (ADR), morbidity and mortality because of poor regulations and implementation of preventive measures. These countries try to copy/follow guidelines from international bodies like American Urology Association (AUA), European Association of Urology (EAU), AGS, UMC and WHO irrespective of their country of origin and success in implementation. Although recommendations of these organizations are obligatory, yet these are taken as the gold standard for good clinical practices. This manuscript highlights difference in view point of various apex health organizations in formulating health policies for prevention, diagnosis, treatment and ADR monitoring for urological disorders. Lacking role of regulatory bodies in implementation of existing policies may lead to potentially inappropriate medication and produce a great economic burden. This analysis has prompted us to recommend that these apex bodies should have better coordination in producing a single value document, make it mandatory part of curricula in medical schools for better awareness, awareness campaigns and separate reporting column in ADR form.

Keywords: AUA/EAU/AGS; Beer criteria/STOPP START criteria; UMC/WHO guidelines; Urological disorders.

Fig. 1

Gap between apex bodies for geriatric health. UMC: Uppsala Monitoring Centre; WHO: World Health Organization; AGS: American Geriatrics Society; AUA: American Urological Association; EAU: European Association of Urology.